Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r102 Activators

Chemical activators of Vmn2r102 can influence its activity through a variety of intracellular signaling pathways. Acetylcholine, for example, can initiate activation of Vmn2r102 by interacting with muscarinic receptors, which are known to trigger downstream signaling cascades that activate this protein. Similarly, norepinephrine can activate Vmn2r102 through its action on adrenergic receptors, which are coupled with the protein's activation via secondary messenger systems. These messengers further propagate the signal within the cell, resulting in the activation of Vmn2r102. Histamine, by binding to H1 receptors, sets off another signaling cascade that activates Vmn2r102, while dopamine engages either D1-like or D2-like receptors, leading to direct cellular signaling changes that include the activation of Vmn2r102. Serotonin, which acts on 5-HT receptors, and glutamate, through NMDA receptors, also play roles in modulating intracellular pathways that result in the activation of Vmn2r102.

In addition to these neurotransmitters, other chemicals can also activate Vmn2r102. GABA's interaction with GABAergic receptors and glycine's binding to glycine receptors can modulate chloride channel-mediated signaling, which in turn activates Vmn2r102. The adrenal hormone epinephrine engages beta-adrenergic receptors, influencing pathways that activate Vmn2r102, and adenosine triphosphate (ATP) activates Vmn2r102 through purinergic receptors that stimulate a signaling cascade. Anandamide activates Vmn2r102 by binding to cannabinoid receptors that are linked to Vmn2r102's signaling mechanisms. Lastly, nitric oxide serves as an activator of Vmn2r102 through soluble guanylate cyclase pathways, leading to cGMP-mediated activation of Vmn2r102. Each of these chemicals, through their specific receptor interactions and subsequent intracellular signaling events, ensures the activation of Vmn2r102, playing a role in the complex web of cellular communication.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

L-Noradrenaline

51-41-2sc-357366
sc-357366A
1 g
5 g
$326.00
$485.00
3
(0)

Norepinephrine binds to adrenergic receptors that are coupled with Vmn2r102 activation through secondary messenger systems.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Histamine initiates its effect by binding to H1 receptors, causing a cascade that results in the activation of Vmn2r102.

Dopamine

51-61-6sc-507336
1 g
$290.00
(0)

Dopamine activates Vmn2r102 by engaging D1-like or D2-like receptors, which leads to direct changes in cellular signaling.

Serotonin hydrochloride

153-98-0sc-201146
sc-201146A
100 mg
1 g
$118.00
$187.00
15
(1)

Serotonin activates Vmn2r102 through its action on 5-HT receptors, which modulate intracellular pathways linked to Vmn2r102.

L-Glutamic Acid

56-86-0sc-394004
sc-394004A
10 g
100 g
$297.00
$577.00
(0)

Glutamate activates Vmn2r102 through NMDA receptors, triggering intracellular signaling that includes activation of Vmn2r102.

GABA

56-12-2sc-203053
sc-203053A
sc-203053B
sc-203053C
10 g
25 g
5 kg
10 kg
$64.00
$136.00
$459.00
$765.00
2
(1)

GABA can activate Vmn2r102 indirectly by modulating GABAergic receptors that interact with Vmn2r102 signaling pathways.

Glycine

56-40-6sc-29096A
sc-29096
sc-29096B
sc-29096C
500 g
1 kg
3 kg
10 kg
$41.00
$71.00
$112.00
$357.00
15
(9)

Glycine binds to glycine receptors, which can lead to the activation of Vmn2r102 via chloride channel-mediated signaling.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine engages beta-adrenergic receptors influencing signaling pathways that result in Vmn2r102 activation.

Adenosine 5′-Triphosphate, disodium salt

987-65-5sc-202040
sc-202040A
1 g
5 g
$39.00
$75.00
9
(1)

ATP activates Vmn2r102 through purinergic receptors, which stimulate a cascade resulting in Vmn2r102 activation.